By Sarina Isaacs
Shares of Sanara MedTech dropped after the company widened its fourth-quarter loss despite a jump in revenue.
The stock was recently down 11% at $31.77. Shares are off about 12% over the past year.
The Fort Worth, Texas-based company said Tuesday it lost $1.5 million, or 18 cents a share, compared with a loss of $237,000, or three cents a share, in the same quarter a year earlier.
Revenue rose 49% to $26.3 million, primarily driven by sales of soft-tissue products in its surgical segment, said Chief Executive Ron Nixon.
Operating expenses rose by 51% to $24.4 million from $16.1 million in the prior year, including higher overhead and research-and-development costs. Interest expenses more than tripled year over year to $1.29 million from $287,000.
Write to Sarina Isaacs at sarina.isaacs@wsj.com
(END) Dow Jones Newswires
March 25, 2025 11:14 ET (15:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。